You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOLFOX failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))

Recruiting
  • Rectal Cancer
  • mFOLFOX (neoadjuvant)
  • +6 more
  • Mannheim, Germany
    Unversity Hospital Mannheim
Aug 12, 2022

Metastatic Pancreatic Cancer Trial in Fairhaven, Providence (FOLFOXA)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • Fairhaven, Massachusetts
  • +1 more
Jul 27, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Metastatic Colorectal Cancer Trial in France, Martinique (FOLFOX + panitumumab)

Recruiting
  • Metastatic Colorectal Cancer
  • FOLFOX + panitumumab
  • Sainte Colombe, Lyon, France
  • +45 more
Mar 23, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Failure in Metastatic Colorectal Cancer Patients

Recruiting
  • Colorectal Cancer Metastatic
    • Montreal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal (CHUM)
    Nov 11, 2022

    Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

    Recruiting
    • Locally Advanced Colorectal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
    Nov 23, 2023

    Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

    Completed
    Has Results
    • Unresectable Adenocarcinoma of the Esophagus
    • +3 more
    • Los Angeles, California
    • +1 more
    Sep 3, 2021

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

    Active, not recruiting
    • Adenocarcinoma of the Esophagus
    • +5 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jul 25, 2022

    Rectal Cancer Trial in Dallas (Ultrafractionated radiotherapy for rectal cancer)

    Recruiting
    • Rectal Cancer
    • Ultrafractionated radiotherapy for rectal cancer
    • Dallas, Texas
      UT Southwestern Medical Center
    Nov 30, 2022

    GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

    Recruiting
    • GastroEsophageal Cancer
    • Gastric Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 25, 2023

    Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Shanghai, China
      Zhongshan hospital, Fudan University
    Aug 12, 2023

    Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

    Not yet recruiting
    • Gastroesophageal Adenocarcinoma
    • toripalimab FOLFOX
    • (no location specified)
    Aug 3, 2023

    Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)

    Not yet recruiting
    • Rectal Cancer
    • Neoadjuvant Chemoradiotherapy
    • Total Neoadjuvant Therapy
    • (no location specified)
    Oct 24, 2023

    Colorectal Tumors, Colorectal Tumors, Colorectal Carcinoma Trial in Washington, Bethesda (Avelumab, Ad-CEA vaccine, Bevacizumab)

    Terminated
    Has Results
    • Colorectal Tumors
    • +4 more
    • Washington, District of Columbia
    • +1 more
    Dec 10, 2021

    Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)

    Active, not recruiting
    • Adenocarcinoma of the Stomach
    • GastroEsophageal Cancer
    • Amberg, Germany
    • +26 more
    Jan 12, 2023

    Pancreatic Cancer Trial in Worldwide (Pegilodecakin, FOLFOX)

    Completed
    Has Results
    • Pancreatic Cancer
    • Gilbert, Arizona
    • +129 more
    Sep 24, 2020

    Rectal Cancer Trial in Worldwide (M1 scheme, standard long course chemoradiotherapy)

    Active, not recruiting
    • Rectal Cancer
    • M1 scheme
    • standard long course chemoradiotherapy
    • Saint Louis, Missouri
    • +55 more
    Jan 11, 2023

    Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Hepatic Artery Infusion Chemotherapy
    • +3 more
    • (no location specified)
    Feb 7, 2022

    Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

    Recruiting
    • Locally Advanced Rectal Carcinoma
    • +2 more
    • Gainesville, Florida
    • +1 more
    Jan 4, 2023

    Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)

    Not yet recruiting
    • Potentially Resectable Hepatocellular Carcinoma
    • (no location specified)
    Nov 16, 2023

    Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

    Recruiting
    • Unresectable or Metastatic Colorectal Cancer
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Mar 22, 2023

    Pancreatic Cancer Trial in Providence (FOLFOXA)

    Completed
    Has Results
    • Pancreatic Cancer
    • Providence, Rhode Island
    • +1 more
    May 12, 2022

    Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • (no location specified)
    Jul 28, 2022

    Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

    Not yet recruiting
    • Liver Metastasis Colon Cancer
    • TACE and HAIC Combined With Regorafenib
    • Guangzhou, Guangdong, China
      the first affiliated hospital, Sun-Yat sen university
    Oct 2, 2023